APA

Lee E. K., Tan-Wasielewski Z., Matulonis U. A., Birrer M. J., Wright A. A., Horowitz N., Konstantinopoulos P. A., Curtis J. & Liu J. F. (2019). Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. : Gynecologic oncology reports.

Chicago

Lee Elizabeth K, Tan-Wasielewski Zhenying, Matulonis Ursula A, Birrer Michael J, Wright Alexi A, Horowitz Neil, Konstantinopoulos Panagiotis A, Curtis Jennifer and Liu Joyce F. 2019. Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. : Gynecologic oncology reports.

Harvard

Lee E. K., Tan-Wasielewski Z., Matulonis U. A., Birrer M. J., Wright A. A., Horowitz N., Konstantinopoulos P. A., Curtis J. and Liu J. F. (2019). Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. : Gynecologic oncology reports.

MLA

Lee Elizabeth K, Tan-Wasielewski Zhenying, Matulonis Ursula A, Birrer Michael J, Wright Alexi A, Horowitz Neil, Konstantinopoulos Panagiotis A, Curtis Jennifer and Liu Joyce F. Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. : Gynecologic oncology reports. 2019.